Azelby Robert bought ADCT
June 1, 2026 · Form 4 insider transaction
Azelby Robert bought 45,000 shares of ADC Therapeutics SA at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
45,000
Price
$0.00
Total value
N/A
InsiderAzelby Robert
RoleDirector
CompanyADC Therapeutics SA (ADCT)
SecurityCommon Shares
Transaction codeA: Grant or award
Transaction dateJune 1, 2026
Filing dateJune 3, 2026
Shares owned after125,405
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents the annual grant of restricted stock units ("RSUs") made under the Issuer's 2019 Equity Incentive Plan for service as a Director. The RSUs vest on the earlier of (i) one year from the grant date or (ii) the date of the 2027 Annual Meeting of Shareholders, subject to the Reporting Person's continued service to the Issuer. Each RSU represents a contingent right to receive one share of the Issuer's common stock.